This post has expired! It was posted more than 90 days ago.
<- Back

Assessing and Treating Itch

Speciality Classification
Start Date
7 m

Across clinical settings, pruritus (or itch) challenges care outcomes, can be hard to treat, and impacts on quality of life, mental health and mortality. The reason we itch is to protect the skin against noxious stimuli; scratching or rubbing disrupts the irritant. However, too much scratching can inflame the skin and often the cause of pruritus is not an external stimulus at all.

Accompanying many dermatologic conditions due to peripheral stimuli, pruritus also arises from systemic disease (renal, hepatic, endocrine), malignancy and medications – all of which may present as skin disorders, but actually originate in the central nervous system. Pruritus without obvious primary skin lesions should be investigated for an underlying cause.

Whatever its origins, scratching further inflames skin, stimulates nerve fibres, initiating the itch-scratch cycle. As the patient scratches, they damage the skin leading to the release of inflammatory chemicals, which increases the itchy sensation. The itch-scratch cycle alters the structure of the skin by compromising the barrier effect, which can then result in prurigo nodularis or lichenification. As such, assessing and treating itch as early as possible is an important facet of effective patient care.


When assessing pruritus, the following categories will help identify what the underlying cause might be:

  • Dermatologic – an itch associated with skin conditions
  • Systemic – driven by organs other than skin (eg uremia, cholestasis)
  • Neurogenic/Neuropathic – related to the central and peripheral nervous systems, nerve compression or nerve irritation
  • Psychogenic – no dermatologic cause with a psychological component

Varied causes suggest multiple mechanisms may induce pruritus. Sensory nerve endings in the epidermis and dermal-epidermal junction are stimulated by chemical mediators such as histamine, opioids, serotonin  and prostaglandins. Signals are transmitted along unmyelinated, histamine-sensitive and insensitive peripheral C-nerve fibres (as opposed to C-nerve fibres that transmit pain), which causes the sensation of an itch.

characteristics will provide clues to the origin and will indicate the most effective treatment options.

  • Is the itch acute? Something triggers it and a “scratch” usually relieves it.
  • Or is it chronic? Present for more than six weeks and not relieved by scratching.
  • Is it a rash that is itchy or an itch without a rash?
  • Is the itch localised or generalised? Generalised and severe pruritus demands evaluation for systemic disease, which will mean blood tests, physical examination and possibly imaging.

Determining the underlying  cause of pruritus and individualising treatment will require a nursing assessment, which should include a full history as well as a skin examination.

When performing a skin examination ensure that you use adequate lighting to inspect the skin texture and any subtle lesions that may be present. Pay attention to affected and non-affected skin, including web spaces and skin folds. Primary lesions that are unaltered by scratching may indicate a dermatological cause while secondary lesions only (eg excoriations) suggest a systemic cause. Make a note of lesion distribution and contributing conditions, such as dry skin.

When taking the patient’s history the “OLDCARTS” mnemonic formula will help to guide and order your collection of information.

  • Onset – when did it start?
  • Location – localised or generalised? Initial location, progression, distribution (some aetiologies display pruritus in favoured sites)?
  • Duration – acute or chronic?
  • Character – stinging or burning?
  • Aggravating factors – environmental, treatments prescribed or over-the-counter medication?
  • Relieving factors – environmental, treatments prescribed or over-the-counter medication?
  • Timing – is the itch consistently present or does it come and go? Is it seasonal or related to the time of day? Has it been experienced previously? Are there circumstances surrounding appearance such as illness, travel or contacts?
  • Severity – is it so severe that it disrupts sleep?

Be sure to add a detailed medication history, including over the counter medications, natural remedies, new prescription medications and current medications where the dose has been altered.


line of management for mild, localised pruritus are topical therapies. Systemic strategies are added depending on severity and extent. These should be employed in conjunction with the removal of aggrevating external factors.

  • Encourage cooler, shorter showers.
  • Moisturise immediately after bathing in order to improve barrier function and maintain the acid mantle.
  • Cool compresses will relieve heat and assist with hydration of the skin
  • Wet dressings applied with moisturiser can be soothing, but caution must be applied in older people and people with infected skin.
  • Cut fingernails or wear gloves at night to avoid further scratching.
  • Sleep in a cooler environment to avoid overheating.

Additional measures that might be applied depending on the underlying cause:

  • Topical antipruritics such as menthol or oatmeal.
  • Oral antihistamines, although consider the sedating effect.
  • Topical corticosteroids.
  • Phototherapy with a dermatologist’s referral.

Pruritus commonly causes physical and psychological distress. Individual evaluation with considered methodical care and management will help to aid this complex issue and provide much needed relief to your patient.

For further reading, see ‘How to Describe a Rash – A List of Terms and Corresponding Images‘

[show_more more=”Show References” less=”Hide References” align=”center” color=”#808080″]


  • Bernhard, JD 2005, ‘Itch and pruritus: what are they, and how should itches be classified?’, Dermatologic Therapy, vol. 18, pp. 288–291, viewed 22 August 2015 http://web.pdx.edu/(…).pdf
  • Bin saif, GA, Ericson, ME & Yosipovitch, G 2011, ‘The Itchy scalp – scratching for an explanation’, Exp Dermatol, vol. 20 no.12, pp. 959–968. doi:10.1111/j.1600-0625.2011.01389.x. viewed 22 August 2015 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233984/pdf/nihms-331222.pdf
  • Ersser, SJ 2010, ‘Assessment and planning care’, in R Penzer & S Ersser (eds.), Principles of skin care. A guide for nurses and other health care professionals, Blackwell-Wiley, Malaysia
  • Fazio, S & Yosipovitch, G 2015, ‘Pruritus: Etiology and patient evaluation’, viewed 22 August 2015, http://www.uptodate.com/contents/pruritus-etiology-and-patient-evaluation
  • Garibyan, L, Rheingold, CG & Lerner, EA 2013, ‘Understanding the pathophysiology of itch’, Dermatol Ther. Vol. 26 no. 2. doi:10.1111/dth.12025. viewed 22 August 2015 http://www.ncbi.nlm.nih.gov/(…).pdf
  • Karnath, B A 2005, ‘Pruritus: A sign of underlying disease’, Hospital Physician, pp 25-29, viewed 21 August 2015, http://www.turner-white.com/memberfile.php?PubCode=hp_oct05_pruritus.pdf
  • Patel, T & Yosipovitch, G 2010, ‘Therapy of Pruritus’, Expert Opinion on Pharmacotherapy, vol. 11, no. 10, pp. 1673–1682. doi:10.1517/14656566.2010.484420, viewed 22 August 2015 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885583/
  • Reamy, BV, Bunt, CW & Fletcher, S 2011, ‘A Diagnostic Approach to Pruritus’, American Family Physician, vol. 84 no. 2, pp. 195-202. Viewed 22 August 2015 http://www.aafp.org/afp/2011/0715/p195.html
  • Reich, A, Ständer, S, & Szepietowski, JC 2009, ‘Drug-induced Pruritus: A Review’, Acta Derm Venereol, vol 89, no 3, pp. 236-244, viewed 21 August 2015, http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-0650&html=1
  • Yosipovitch, G & Hundley, JL 2004, ‘Practical Guidelines for Relief of Itch’, Dermatology Nursing, vol. 16, no. 4 viewed 22 August 2015 http://mediskin.cn/(…).pdf


Author Jan Riley

Jan Riley is a specialist dermatology nurse based in regional New South Wales, Australia. Her postgraduate studies include a Certificate in Dermatology Nursing (USA), Master of Nursing (NP) and Certificates in Dermoscopy and Skin Cancer Medicine. Driven by a passion for “all things skin”, Jan is a staunch and passionate mentor and advocate, who is always ready and willing to share knowledge and inspire nurses to understand skin’s impact on daily lives. Her active participation in a range of professional activities has greatly assisted to raise the profile of dermatology and skin disease in the community. Jan currently develops and presents skin education modules through a co-directed nurse education company (Dermatology Nurse Education Australia) for nurses across all areas of care delivery. See Educator Profile

Assessing and Treating Itch
Speciality Classification
Provider Type
7 m
Start Date
CPD Points
7 m
Price Details
$30 p/m
Posted By